Consolidated Statement of Income
| € millions |
See Note |
2024 |
2023 |
| Sales |
6 |
39,719 |
41,421 |
| Cost of sales |
|
–30,918 |
–32,613 |
| Gross margin on sales |
|
8,800 |
8,808 |
| Research and development expenses |
7 |
–4,099 |
–4,126 |
| Selling and logistics expenses |
|
–2,580 |
–2,528 |
| Administrative expenses |
|
–1,270 |
–1,355 |
| Other income |
8 |
2,054 |
1,837 |
| Other expenses |
8 |
–650 |
–829 |
| Income from equity-accounted investees |
10 |
32 |
45 |
| Other income from investments |
10 |
0 |
1 |
| EBIT |
|
2,287 |
1,854 |
| Interest income |
11 |
103 |
103 |
| Interest expense |
11 |
–449 |
–419 |
| Effects from currency translation |
11 |
–2 |
79 |
| Effects from changes in the fair value of derivative instruments, and other valuation effects |
11 |
–51 |
1 |
| Financial result |
11 |
–398 |
–236 |
| Earnings before tax |
|
1,888 |
1,618 |
| Income tax expense |
12 |
–689 |
–424 |
| Net income |
|
1,200 |
1,194 |
| Non-controlling interests |
|
–32 |
–37 |
| Net income attributable to the shareholders of the parent |
|
1,168 |
1,156 |
| |
|
|
|
| Basic earnings per share in € |
38 |
5.84 |
5.78 |
| Diluted earnings per share in € |
38 |
5.84 |
5.78 |
